Article Text

Download PDFPDF

IS-039 Antioxidant Strategies: Where Are We Now?
  1. F van Bel
  1. Neonatology, University Medical Center Utrecht, Utrecht, Netherlands


Part of asphyxia-related brain damage occurs upon reoxygenation. Renewed availability of oxygen activate biochemical pathways and neuronal cell death. Important pathways are: 1) Calcium-induced formation of neurotransmitters; 2) formation of (pro-) radicals; 3) activation of inflammation; 4) induction of apoptosis; 5) depletion of growth factors. Four important sources of free radicals are: 1) Nitric oxide (NO)-related formation of peroxynitrite. It is reported that selective iNOS/eNOS inhibitor 2-iminobiotin induced neuroprotection after asfyxia in animal models. 2) Pro-radicals, such as non proteinbound-iron (NPBI), lead to formation of hydroxyl free radicals. NPBI chelation with deferoxamine, which has also a stabilising effect on HIF1-alpha and stimulates trophic factors, showed encouraging results in experimental models. 3) Formation of superoxide radical by metabolisation by xanthine-oxidase (XO) can be blocked by XO-inhibitors such as allopurinol. 4) Metabolisation of arachidonic acid to prostaglandin leading to superoxide can be blocked by cyclo-oxygenase inhibitors. Since XO-derived superoxide occurs upon reoxygenation after asphyxia, a trial with allopurinol to the mother with signs of perinatal fetal hypoxia has been started. Activation of inflammatory factors after asphyxia is recognised to be related to post-aphyxial brain damage.

Rather than monotherapy directed to one pathway, a combination of drugs intervening in various pathways in relation with the time-profile of these pathways, might achieve optimal reduction of reperfusion injury.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.